Analystreport

Agile Therapeutics Inc (NASDAQ: AGRX) had its "buy" rating re-affirmed by analysts at Maxim Group.

Agile Therapeutics, Inc.  (AGRX) 
Last agile therapeutics, inc. earnings: 5/2 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations